By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



Corporate Headquarters
One Amgen Center Drive
Thousand Oaks  California  91320-1789  U.S.A.
Phone: 805-447-1000 Fax: 805-447-1010


Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology.

Amgen focuses on areas of high unmet medical need and leverages its biologics manufacturing expertise to strive for solutions that improve health outcomes and dramatically improve people's lives. A biotechnology pioneer since 1980, Amgen has grown to be one of the world's leading independent biotechnology companies, has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential.

For more information, visit, LinkedIn and follow us on


Key Statistics

Ownership: Public

Web Site: Amgen
Employees: 20,000
Symbol: AMGN

Company News
A Look at Who's the Better Buy: Amgen (AMGN) or Celgene (CELG) 1/17/2017 8:52:26 AM
Amgen (AMGN) Release: Study Results Published In JAMA Show Company's Parsabiv (Etelcalcetide) Significantly Reduced Serum Parathyroid Hormone In Adults With Secondary Hyperparathyroidism On Hemodialysis 1/11/2017 7:06:54 AM
Amgen (AMGN) Release: Pharma Statement On January 9, 2017, U.S. District Court Decision 1/10/2017 9:52:32 AM
Regeneron (REGN) CEO Says Amgen (AMGN) Not Putting Patients First In Patent Dispute 1/10/2017 6:58:53 AM
e-Therapeutics Release: Appointment Of Amgen (AMGN) Executive Director As Chief Executive 1/9/2017 10:04:17 AM
This German Biotech Just Inked a $1 Billion+ Cancer Deal With Biotech Giant Amgen (AMGN) 1/9/2017 5:35:53 AM
Court Grants Permanent Injunction For Infringement Of Amgen (AMGN)'s Repatha Patents 1/6/2017 2:17:46 PM
Adaptive Biotech Announces A Collaboration With Amgen (AMGN) To Advance Development Of Clonoseq Assay In Acute Lymphoblastic Leukemia 1/6/2017 10:43:20 AM
SiteOne Therapeutics Announces Research and Development Agreement With Amgen (AMGN) to Advance Portfolio of Highly Selective, Potent Inhibitors of NaV1.7 for Acute and Chronic Pain 1/6/2017 7:54:10 AM
Amgen (AMGN) Shares Soar After Blocking Rivals From Selling Competing Cholesterol-Lowering Drug 1/6/2017 7:38:46 AM